通过EGFR氨酸激酶依赖途径,SMEK1促进清细胞细胞癌的进展
Jue Wang1, Wenhao Bi2, Renguang Lv3
1Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Medical Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China; Institute of Medical Sciences, The Second Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250033, China.
Cancer letters
|August 4, 2024
概括
蛋白酸酶4组成部分SMEK1的高表达通过调节EGFR信号来促进清细胞细胞癌 (ccRCC) 的进展. 这一发现为针对ccRCC的药物开发提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 清细胞细胞癌 (ccRCC) 是最常见的癌亚型,具有有限的向药物选择.
- 蛋白酸酶4 (PP4) 与癌症生物学有关,但其在ccRCC中的特定作用需要进一步阐明.
- 了解ccRCC机制对于开发有效的向治疗至关重要.
研究的目的:
- 调查PP4成分SMEK1在ccRCC病变发生过程中的作用.
- 阐明SMEK1影响ccRCC进展的分子机制.
- 在E2F1/SMEK1/EGFR信号轴内识别潜在的治疗点.
主要方法:
- 组织微阵列用于评估ccRCC组织中的SMEK1表达.
- 进行了细胞功能和动物实验,以评估SMEK1的促进瘤效应.
- 用RNA测序 (RNA-seq) 和分子实验 (包括染色体免疫沉) 来确定潜在的机制.
- 使用氨酸激酶抑制剂 (erlotinib) 来评估路径依赖性.
主要成果:
- 在ccRCC中,SMEK1是上调调节的,并且与患者存活时间的减少有关.
- 通过增强细胞运动性和调节EGFR通路,SMEK1促进ccRCC的进展.
- SMEK1与PRMT5相互作用,通过组织素甲基化促进EGFR转录.
- E2F1直接与SMEK1促进器结合,推动ccRCC的进展.
结论:
- 过度表达SMEK1驱动ccRCC通过一种新的E2F1/SMEK1/PRMT5/EGFR信号通路的进展.
- SMEK1是ccRCC的潜在治疗点.
- 已识别的途径提供了关于ccRCC病原和药物开发策略的见解.
相关概念视频
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:07MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K